CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinomaYoung Woon Chang(Seoul National University), Jung‐Hwan Yoon(Seoul National University)BMC CancerOctober 15, 202010.1186/s12885-020-07471-3Cited by 10SaveCiteExport RISWatch citationsRelated PapersModified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14|PLoS ONE|2016|48Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth|Oncology Reports|2011|24